[Translation] A phase I clinical study to evaluate the safety, tolerability and clinical efficacy of allogeneic adipose-derived mesenchymal stem cells (hADSCs) in the treatment of knee osteoarthritis
Main purpose:
Evaluate the clinical safety and tolerability of hADSCs in the treatment of subjects with knee osteoarthritis, and recommend a safe dose range and RP2D for subsequent studies of this product.
Secondary purpose:
Preliminary evaluation of the effectiveness of hADSCs in the treatment of subjects with knee osteoarthritis, and provide a basis for the design of subsequent clinical trial programs.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.